Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection
Lagousi, T.; Routsias, J.; Mavrouli, M.; Papadatou, I.; Geropeppa, M.; Spoulou, V. Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection. Vaccines 2022, 10, 1210. https://doi.org/10.3390/vaccines10081210
Lagousi T, Routsias J, Mavrouli M, Papadatou I, Geropeppa M, Spoulou V. Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection. Vaccines. 2022; 10(8):1210. https://doi.org/10.3390/vaccines10081210
Chicago/Turabian StyleLagousi, Theano, John Routsias, Maria Mavrouli, Ioanna Papadatou, Maria Geropeppa, and Vana Spoulou. 2022. "Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection" Vaccines 10, no. 8: 1210. https://doi.org/10.3390/vaccines10081210